[Recent advances in therapy for chronic glomerular diseases].
Nitta
Kosaku
K
Department of Medicine, Kidney Center,Tokyo Women's Medical University.
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000209:etiology / Q000628:therapy*; D005921:Glomerulonephritis / Q000178:diet therapy / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D014068:Tonsillectomy
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D008775:Methylprednisolone